https://www.selleckchem.com/products/og-l002.html
29 to -8.04; p = 0.0007), lengthened the time of first request of analgesia (WMD = 38.90; 95% CI 0.88-76.93; p = 0.04) and lowered post-operative nausea or vomiting (PONV) (odds ratio (OR) = 0.49; 95% CI 0.27-0.89; p = 0.02). Intravenous DEX infusion significantly improved the duration of the analgesic effect and reduced postoperative opioid consumption. Moreover, lower incidence of post-operative nausea or vomiting was found in the DEX group. Intravenous DEX infusion significantly improved the duration of the analgesic effect and reduc
Like
Comment
Share
